Lake Success, NY, United States
Lake Success, NY, United States

Time filter

Source Type

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Congress of Radiology Conference Coverage, 2017" report to their offering. The 2017 European Congress of Radiology (ECR) conference and the exhibition show floor brought together industry participants, radiologists, clinical application specialists, academics, medical professionals, care providers, and a host of other imaging stakeholders to showcase the latest in radiology as well as discuss the challenges the industry faced. The 2017 ECR conference notably had a record attendance of 26,829 participants as per ECR congress attendance statistics. This market insight will allow you to learn about the top trending themes in the Imaging Industry, specific modality trends, and key vendor highlights from various imaging original equipment manufacturers (OEM) in terms of portfolio and positioning. In addition to imaging modality specific highlights, insights on the growth of Clinical Decision Support Systems, the role of Quantitative Imaging and Imaging Biomarkers, developments in Multi-modality Organ Specific Solutions, the growth of Image Guided Interventions, and developments in Breast Imaging have also been covered. For more information about this report visit http://www.researchandmarkets.com/research/fjxr3q/european_congress


SALEM, N.H. & PHILADELPHIA--(BUSINESS WIRE)--Gamma Medica, a leader in molecular breast imaging (MBI) technology, today announced that Einstein Medical Center Philadelphia has installed Pennsylvania’s first clinical LumaGEM® Molecular Breast Imaging system. MBI is a proven, effective supplementary screening method to standard mammography and/or tomosynthesis (3D mammography), significantly increasing early detection of breast cancer in women.1 In the U.S., approximately 50 percent of women are reported to have dense breast tissue, but many women do not realize they have dense breasts or the implications dense breast tissue has on increasing their lifetime risk of breast cancer.2 Dense breast tissue and cancer both appear white on mammograms making it difficult to distinguish between the two. It’s like trying to find a snowflake in a snowstorm, which can lead to false negatives or delayed diagnoses.3 “The new installation of the LumaGEM MBI system at Einstein Medical Center Philadelphia now gives women access to a clinically superior diagnostic and secondary breast screening method,” said Philip Croxford, president and CEO of Gamma Medica. “LumaGEM MBI provides the opportunity for personalized breast screenings in women who are at higher risk of being diagnosed with breast cancer, in effect raising the standard in breast cancer detection. We look forward to continued collaboration with the hospital and its affiliates with the goal of improving the lives of women in the area.” A breakthrough retrospective clinical study published in the August issue of the American Journal of Roentgenology confirmed MBI’s high incremental cancer detection rate: MBI was able to detect 7.7 cancers per 1,000 women screened that were not found using mammography. Approximately 85 percent of these cancers were invasive and 82 percent of the invasive cancers were also node negative, meaning they were detected at an earlier stage and presented a better prognosis. 4 While mammograms may fail to detect breast tumors due to tissue density, MBI highlights metabolic activity in these tumors despite breast density, leading to an earlier diagnosis. “I’m excited about adding this technology to our program so we can help screen so many of our patients who have dense breast tissue,” said Debra Somers Copit, MD, director of breast imaging for Einstein Healthcare Network. About Gamma Medica, Inc. Gamma Medica, Inc. is a women’s health company focused on overcoming the limitations of anatomical imaging experienced by mammography and other screening modalities in the early detection of breast cancer. The company’s LumaGEM® MBI system is the first commercially available, FDA-cleared, fully solid-state digital imaging system utilizing dual-head Digital Direct Conversion Gamma Imaging™ (DDCGI™) technology for molecular breast imaging. With over 90 percent sensitivity and specificity, LumaGEM MBI has been shown to significantly improve cancer detection in women with dense breast tissue with fewer false positives relative to anatomical imaging technologies, such as MRI and whole breast ultrasound. For more information visit, www.gammamedica.com. About Einstein Healthcare Network Einstein Healthcare Network is a 1,044-bed integrated delivery network with more than 8,500 employees serving the communities of Philadelphia and Montgomery County, Pa. Einstein Medical Center Philadelphia is the largest independent academic medical center in the Philadelphia region training over 3,500 health professional students each year with 400 residents in more than 30 accredited programs. The network also provides a comprehensive range of healthcare services through Einstein Medical Center Elkins Park, Einstein Medical Center Montgomery, MossRehab, Willowcrest, outpatient care centers, and a network of more than 700 primary care physicians and specialists throughout the region. For more information, visit www.einstein.edu or call 1-800-EINSTEIN. 1 Rhodes DJ, Hruska CB, Conners AL, et al. JOURNAL CLUB: Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts. American Journal of Roentgenology. 2 Mandelson MT, et al. J Natl Cancer Inst. 2000; 92: 1081-7 3 Mayo Clinic. Tests and Procedures Mammogram. http://www.mayoclinic.org/tests-procedures/mammogram/in-depth/dense-breast-tissue/art-20123968?pg=2 4 Shermis, RB, Wilson, K, et al. Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue. American Journal of Roentgenology. August 2016.


News Article | May 9, 2017
Site: www.prnewswire.com

NEW YORK, May 9, 2017 /PRNewswire/ -- Top Trending Themes, Modality Trends, and Vendor Highlights from the ECR17 The 2017 European Congress of Radiology (ECR) conference and the exhibition show floor brought together industry participants, radiologists, clinical application specialists, academics, medical professionals, care providers, and a host of other imaging stakeholders to showcase the latest in radiology as well as discuss the challenges the industry faced. The 2017 ECR conference notably had a record attendance of 26,829 participants as per ECR congress attendance statistics. Read the full report: http://www.reportlinker.com/p04886827/European-Congress-of-Radiology-Conference-Coverage.html This market insight will allow you to learn about the top trending themes in the Imaging Industry, specific modality trends, and key vendor highlights from various imaging original equipment manufacturers (OEM) in terms of portfolio and positioning. The following Medical Imaging Modalities have been covered in this market insight: • Magnetic Resonance Imaging (MRI) • Computed Tomography (CT) • Digital Radiography (DR) • Ultrasound (US) • Image Guided Interventions including Interventional X-ray and Image Guided Therapy (IGT) • Contrast Auto-Injectors In addition to imaging modality specific highlights, insights on the growth of Clinical Decision Support Systems, the role of Quantitative Imaging and Imaging Biomarkers, developments in Multi-modality Organ Specific Solutions, the growth of Image Guided Interventions, and developments in Breast Imaging have also been covered. Read the full report: http://www.reportlinker.com/p04886827/European-Congress-of-Radiology-Conference-Coverage.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/european-congress-of-radiology-conference-coverage-2017-300454542.html


WEST BLOOMFIELD, Mich. & SALEM, N.H.--(BUSINESS WIRE)--Gamma Medica, a leader in molecular breast imaging (MBI) technology, today announced that the Henry Ford Cancer Institute has installed Gamma Medica’s LumaGEM® Molecular Breast Imaging system, which is the first MBI machine in Michigan. MBI is a proven, effective supplementary screening method to standard mammography and/or tomosynthesis (3D mammography), significantly increasing early detection of breast cancer in women.1 The new system can be found at the Henry Ford West Bloomfield Hospital where it will provide diagnostic and secondary screenings to women who have a higher risk of breast cancer and with dense breast tissue. Approximately 50 percent of U.S. women are reported to have dense breast tissue. Unfortunately, many do not realize that they have dense tissue, or the implications dense breast tissue has on increasing their lifetime risk of breast cancer.2 Additionally, both dense breast tissue and cancer appear white on mammograms, making it difficult to distinguish between the two. It’s like trying to find a snowflake in a snowstorm, which can lead to false negatives or delayed diagnoses.3 “The new installation of the LumaGEM MBI system at the Henry Ford Cancer Institute gives women in Michigan and surrounding areas access to a clinically superior diagnostic and secondary breast screening method,” said Philip Croxford, president and CEO of Gamma Medica. “We are delighted to be able to partner with the Henry Ford Cancer Institute and look forward to collaborating with them to help improve early cancer detection for women who are at greater risk. We believe MBI will ensure that more women have the opportunity to receive personalized breast screenings and improved clinical outcomes.” A prospective study conducted by the Mayo Clinic in Rochester, MN found that the addition of MBI to mammography significantly increased the detection of breast cancer in women with dense breast tissue.4 The following year, a retrospective clinical study published in the American Journal of Roentgenology’s August 2016 issue confirmed these findings. This study involved nearly 1,700 women with dense breast tissue over a three year period and found that LumaGEM had an incremental cancer detection rate of 7.7 cancers per thousand (7.7/1000) over mammography (which detects 3.0/1000 alone). Approximately 85 percent of the cancers found in the study were confirmed to be invasive, of which 82 percent were node negative, indicating they were detected at an early stage and therefore presented a better prognosis.5 Clinical research also showcases that the use of LumaGEM reduces biopsies, often painful and costly, by 50 percent, compared to other modalities.6 The MBI procedure requires minimal breast compression; patients are able to sit comfortably throughout the exam and results are typically available the same day. “The Henry Ford Cancer Institute offers some of the most advanced screening options available to our patients, and this technology brings added imaging capability for women with dense breast tissue,” says Patricia Miller, M.D., director of Breast Imaging at Henry Ford West Bloomfield Hospital. The new technology was made possible by philanthropic support and donations. About Gamma Medica, Inc. Gamma Medica, Inc. is a women’s health company focused on overcoming the limitations of anatomical imaging experienced by mammography and other screening modalities in the early detection of breast cancer. The company’s LumaGEM® MBI system is the first commercially available, FDA-cleared, fully solid-state digital imaging system utilizing dual-head Digital Direct Conversion Gamma Imaging™ (DDCGI™) technology for molecular breast imaging. With over 90 percent sensitivity and specificity, LumaGEM MBI has been shown to significantly improve cancer detection in women with dense breast tissue with fewer false positives relative to anatomical imaging technologies, such as MRI and whole breast ultrasound. For more information visit, www.gammamedica.com. About the Henry Ford Cancer Institute The Henry Ford Cancer Institute is one of the largest cancer programs in Michigan, providing care at four hospitals and four outpatient facilities throughout southeast Michigan. Treatment for the most complex or rare cancers and the Institute’s extensive cancer research program is anchored by Henry Ford Hospital. For more information, visit www.henryford.com/cancer. 1 Rhodes DJ, Hruska CB, Conners AL, et al. JOURNAL CLUB: Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts. American Journal of Roentgenology. 2015;204(2):241-251. 2 Mandelson MT, et al. J Natl Cancer Inst. 2000; 92: 1081-7 3 Mayo Clinic. Tests and Procedures Mammogram. http://www.mayoclinic.org/tests-procedures/mammogram/in-depth/dense-breast-tissue/art-20123968?pg=2 4 Rhodes DJ, Hruska CB, Conners AL, et al. JOURNAL CLUB: Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts. American Journal of Roentgenology. 2015;204(2):241-251. 5 Shermis, RB, Wilson, K, et al. Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue. American Journal of Roentgenology. August 2016. 6 Rhodes DJ, Hruska CB, Conners AL, et al. JOURNAL CLUB: Molecular Breast Imaging at Reduced Radiation Dose for Supplemental Screening in Mammographically Dense Breasts. American Journal of Roentgenology. 2015;204(2):241-251.


News Article | May 20, 2017
Site: marketersmedia.com

— Renowned commercial property developer Jacob Frydman has been a long time contributor to the Brem Foundation and its thorough work towards early-detection through education, access, and physician training. Inspired by Dr. Rachel Brem, who directs The Breast Imaging and Intervention Center at The GW Medical Faculty Associates, the Brem Foundation is dedicated to helping women understand the risks and options associated with breast cancer. It also provides free breast cancer screenings for the underserved communities within the Washington DC metropolitan area. Generous contributions from donors like Jacob Frydman support the Brem Foundation’s community outreach programs, breast radiologist fellowships, and research in advanced diagnostic technologies. Recognizing the importance of the organization’s fight against the disease, Frydman points to the National Cancer Institute’s findings that in 2015, there were more than 230,000 new cases of breast cancer in the United States and more than 12 percent of women will be diagnosed with the disease in their lifetime. In addition to education provided by the Brem Foundation through its outreach programs, the organization is also devoted to delivering access to those who need it. The foundation’s B-Fund pays for women who cannot afford critical diagnostic tests, while its “Mammovan” brings mobile mammography to the uninsured and underinsured residents of Northern Virginia as well as Montgomery and Prince Georges Counties of Maryland. “While breast cancer may not be preventable, with early diagnosis and treatment, survival rates skyrocket,” states Frydman, citing NCI statistics revealing a 98.6 percent five-year survival rate for those whose cancer is localized. “The Brem Foundation’s mobile mammography is a critical piece of the survivability puzzle,” he adds. Frydman’s support of the Brem Foundation’s work in underserved communities is rooted in part by his experiences growing up in Northern New Jersey, where Frydman saw firsthand the disparities between communities that had financial resources and those that did not. “I greatly admire Dr. Brem’s work in delivering healthcare to women who might otherwise be denied access to basic screening services,” he declares. A renowned expert on value added investments, Jacob Frydman has over 30 years of experience in structuring, financing, and executing highly complex real estate transactions with notable transactions including midtown Manhattan’s Two Dag Hammarskjöld Plaza and lower Manhattan’s Aetna Building. Prior to his retirement in September 2015, Frydman was the CEO and Chairman of a public Real Estate Investment Trust. After his retirement as CEO, he continued on as the Chief Investment Officer of the First Capital Real Estate Trust. Frydman is a graduate of Boston University, where he received his Bachelor’s degree in Finance and Case Western Reserve University School of Law, where he received his Juris Doctor. Mr. Frydman often participates as a speaker and panelist at numerous industry seminars and on Fox Business, CNBC, Bloomberg Television and other news media, where he speaks on matters relating to property investments and trends in real estate. In addition to his support for the Brem Foundation to Defeat Breast Cancer, Frydman also devotes time and capital to organizations such as the Chabad of Dutchess County and served as a member of the Board of Directors of the Bardavon Opera House, home to the Hudson Valley Philharmonic. For more information, please visit http://www.JacobFrydmanNews.com


Receive press releases from iHealthcareAnalyst, Inc.: By Email Global Medical Devices Market Research Reports, Competitive Analytics, Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. Medical Devices Market reports by iHealthcareAnalyst, Inc. include Ablation Technologies, Acute Care Needleless Connectors, Anesthesia Devices, Angioplasty Balloons, Arthroscopy Devices, Artificial Vital organs and Medical Bionics, Atrial Fibrillation, Audiology Devices, Autoinjectors, Bag Valve Masks, Biodegradable Stents, Biomedical Refrigerators and Freezers, Biopsy Devices, Blood Flow Measurement Devices, Blood Pressure Monitoring Devices, Blood Pressure Monitoring Testing, etc. Maryland Heights, MO, May 20, 2017 --( The global Medical Devices market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments. Browse Global Medical Devices Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/medical-devices/ Table of Contents 1. Introduction 2. Executive Summary 2.1. Market Size Estimation (Revenue USD Million, 2014-2021) 2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021) 3. Research Methodology 4. Market Landscape 4.1. Market Dynamics 4.1.1. Drivers 4.1.2. Barriers 4.1.3. Opportunities 4.2. Market Share Analysis 4.2.1. Companies 4.2.2. Devices 4.3. Market Trends Analysis 4.3.1. Key success factors 4.3.2. Market Growth Rate 4.4. Market Attractiveness Analysis 4.5. Market Profitability Analysis 4.5.1. Buyer power 4.5.2. Supplier power 4.5.3. Barriers to entry 4.5.4. Threat of substitute products 4.5.5. Rivalry among firms in the industry 4.6. Distribution Channels 5. Market Segmentation 5.1. Device or Brand Type 5.2. Diagnostic Test 5.3. Indication Type 5.4. Technology 5.5. Diagnostics, Therapeutic or Surgical Application 5.6. End User Groups 6. Geography (Region, Country) 6.1. North America (U.S., Canada) 6.2. Latin America (Brazil, Mexico, Rest of LA) 6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 6.4. Asia Pacific (Japan, China, India, Rest of APAC) 6.5. Rest of the World 7. Regulatory Overview 7.1. Device Classification I, II, III, IV 7.2. Device (FDA, EMEA) Approvals 8. Company Profiles 8.1. Company Overview 8.2. Financial Snapshot (FY 2014-2016) 8.3. Product Portfolio 8.4. Business Strategies 8.5. Recent Developments 9. Recommendations 10. References To request Table of Contents and Sample Pages of these reports visit: https://www.ihealthcareanalyst.com/reports/medical-devices/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 20, 2017 --( PR.com )-- The published titles of Medical Devices Market reports by iHealthcareAnalyst, Inc. include Ablation Technologies, Acute Care Needleless Connectors, Anesthesia Devices, Angioplasty Balloons, Arthroscopy Devices, Artificial Vital organs and Medical Bionics, Atrial Fibrillation, Audiology Devices, Autoinjectors, Bag Valve Masks, Biodegradable Stents, Biomedical Refrigerators and Freezers, Biopsy Devices, Blood Flow Measurement Devices, Blood Pressure Monitoring Devices, Blood Pressure Monitoring Testing, Blood Processing Products and Consumables, Bone Densitometers, Bone Grafts and Bone Grafts Substitutes, Breast Imaging Devices, Breast Pumps, Breath Analyzers, Cardiac Pacemakers, Cardiac Prosthetic Devices, Cardiopulmonary Stress Testing Devices, Cardiovascular Monitoring and Diagnostic Devices, Cerebrospinal Fluid Management, Cleanroom Consumables, Compression Therapy Devices Devices, Cone Beam Computed Tomography, Continuous Glucose Monitoring, Contrast Media Injectors, Coronary Stents, Cosmetic Implants, Craniomaxillofacial Implants, D-Dimer Testing, Deep Brain Stimulation Devices for Parkinson's Disease, Defibrillators, Dental Consumables, Dental Laboratories, Dental Prosthetic Devices, Disposable Syringes, Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Drugs of Abuse Testing, Elderly and Disabled Assistive Devices, Electrical Stimulation Devices, Electrodes for Medical Devices, Electrophysiology Devices, Electrosurgical Devices, Embolization in Interventional Oncology, Endoscopy Devices, Enteral Feeding Devices, Facial Injectables, Fluoroscopy and Mobile C-Arms, Fundus Cameras, Gynecological Devices, Gynecology Devices, Healthcare Bio-MEMS, Healthcare Microfluidics, Hemoglobin Testing Devices, Hernia Repair Devices, Human Reproductive Technologies, Hyperbaric Oxygen Therapy Devices, Image Guided Surgery Devices, Implantable Drug Delivery Devices, Infusion Pumps, Interventional Cardiology Devices, Intracranial Pressure Monitors, Intrathecal Pumps, Intravenous Access Devices, Knee Cartilage Repair, Mechanical Ventilators, Medical Devices Outsourcing, Medical Disposables, Medical Imaging Reagents, Medical Infection Control, Medical Laser Systems, Medical Lifting Slings, Medical Specialty Bags, Microscopy Devices, Minimally Invasive Surgery, Nanotechnology Drug Delivery Systems, Nebulizers, Needle Free Drug Delivery Devices, Negative Pressure Wound Therapy, Nephrology and Urology Devices, Neuromodulation Devices, Nitinol Medical Devices, Novel Drug Delivery Systems for Cancer Therapy, Ophthalmology Diagnostics and Surgical Devices, Optical Imaging, Orthopedic Devices, Orthopedic Soft Tissue Repair, Osteosynthesis Devices, Ostomy Drainage Bags, Oxygen Therapy Devices, Pain Management Devices, Patient Warming Devices, Peripheral Vascular Devices, Personal Mobility Devices, Postpartum Hemorrhage Treatment Devices, Prefilled Syringes, Pre-Owned Devices, Pressure Relief Devices, Pulmonary Drug Delivery Systems, Radiofrequency Ablation Devices, Remote Patient Monitoring Devices, Renal Denervation Devices, Reprocessed Medical Devices, Respiratory Devices, Respiratory Monitoring Devices, Retinal Surgery Devices, Safety Syringes, Self-Care Medical Devices, Sinus Dilation Devices, Skincare Diagnostics and Treatment Devices, Sleep Apnea Diagnostic and Therapeutic Devices, Small Animal Imaging, Small Bone and Joint Orthopedic Devices, Smart Medical Devices, Spinal Trauma Devices, Sports Medicine Devices, Tissue Sealing Agents and Hemostasis, Ultrasound Devices, Unilateral Deafness Treatment Devices, Urinary Catheters, Vitreous Tamponades, Wearable Medical Devices, Wound Closure Devices, Wound Dressing, and X-Ray Devices.The global Medical Devices market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments.Browse Global Medical Devices Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/reports/medical-devices/Table of Contents1. Introduction2. Executive Summary2.1. Market Size Estimation (Revenue USD Million, 2014-2021)2.2. Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)3. Research Methodology4. Market Landscape4.1. Market Dynamics4.1.1. Drivers4.1.2. Barriers4.1.3. Opportunities4.2. Market Share Analysis4.2.1. Companies4.2.2. Devices4.3. Market Trends Analysis4.3.1. Key success factors4.3.2. Market Growth Rate4.4. Market Attractiveness Analysis4.5. Market Profitability Analysis4.5.1. Buyer power4.5.2. Supplier power4.5.3. Barriers to entry4.5.4. Threat of substitute products4.5.5. Rivalry among firms in the industry4.6. Distribution Channels5. Market Segmentation5.1. Device or Brand Type5.2. Diagnostic Test5.3. Indication Type5.4. Technology5.5. Diagnostics, Therapeutic or Surgical Application5.6. End User Groups6. Geography (Region, Country)6.1. North America (U.S., Canada)6.2. Latin America (Brazil, Mexico, Rest of LA)6.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)6.4. Asia Pacific (Japan, China, India, Rest of APAC)6.5. Rest of the World7. Regulatory Overview7.1. Device Classification I, II, III, IV7.2. Device (FDA, EMEA) Approvals8. Company Profiles8.1. Company Overview8.2. Financial Snapshot (FY 2014-2016)8.3. Product Portfolio8.4. Business Strategies8.5. Recent Developments9. Recommendations10. ReferencesTo request Table of Contents and Sample Pages of these reports visit:https://www.ihealthcareanalyst.com/reports/medical-devices/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


-- The published titles of Medical Devices Market reports by iHealthcareAnalyst, Inc. include Ablation Technologies, Acute Care Needleless Connectors, Anesthesia Devices, Angioplasty Balloons, Arthroscopy Devices, Artificial Vital organs and Medical Bionics, Atrial Fibrillation, Audiology Devices, Autoinjectors, Bag Valve Masks, Biodegradable Stents, Biomedical Refrigerators and Freezers, Biopsy Devices, Blood Flow Measurement Devices, Blood Pressure Monitoring Devices, Blood Pressure Monitoring Testing, Blood Processing Products and Consumables, Bone Densitometers, Bone Grafts and Bone Grafts Substitutes, Breast Imaging Devices, Breast Pumps, Breath Analyzers, Cardiac Pacemakers, Cardiac Prosthetic Devices, Cardiopulmonary Stress Testing Devices, Cardiovascular Monitoring and Diagnostic Devices, Cerebrospinal Fluid Management, Cleanroom Consumables, Compression Therapy Devices Devices, Cone Beam Computed Tomography, Continuous Glucose Monitoring, Contrast Media Injectors, Coronary Stents, Cosmetic Implants, Craniomaxillofacial Implants, D-Dimer Testing, Deep Brain Stimulation Devices for Parkinson's Disease, Defibrillators, Dental Consumables, Dental Laboratories, Dental Prosthetic Devices, Disposable Syringes, Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology, Drugs of Abuse Testing, Elderly and Disabled Assistive Devices, Electrical Stimulation Devices, Electrodes for Medical Devices, Electrophysiology Devices, Electrosurgical Devices, Embolization in Interventional Oncology, Endoscopy Devices, Enteral Feeding Devices, Facial Injectables, Fluoroscopy and Mobile C-Arms, Fundus Cameras, Gynecological Devices, Gynecology Devices, Healthcare Bio-MEMS, Healthcare Microfluidics, Hemoglobin Testing Devices, Hernia Repair Devices, Human Reproductive Technologies, Hyperbaric Oxygen Therapy Devices, Image Guided Surgery Devices, Implantable Drug Delivery Devices, Infusion Pumps, Interventional Cardiology Devices, Intracranial Pressure Monitors, Intrathecal Pumps, Intravenous Access Devices, Knee Cartilage Repair, Mechanical Ventilators, Medical Devices Outsourcing, Medical Disposables, Medical Imaging Reagents, Medical Infection Control, Medical Laser Systems, Medical Lifting Slings, Medical Specialty Bags, Microscopy Devices, Minimally Invasive Surgery, Nanotechnology Drug Delivery Systems, Nebulizers, Needle Free Drug Delivery Devices, Negative Pressure Wound Therapy, Nephrology and Urology Devices, Neuromodulation Devices, Nitinol Medical Devices, Novel Drug Delivery Systems for Cancer Therapy, Ophthalmology Diagnostics and Surgical Devices, Optical Imaging, Orthopedic Devices, Orthopedic Soft Tissue Repair, Osteosynthesis Devices, Ostomy Drainage Bags, Oxygen Therapy Devices, Pain Management Devices, Patient Warming Devices, Peripheral Vascular Devices, Personal Mobility Devices, Postpartum Hemorrhage Treatment Devices, Prefilled Syringes, Pre-Owned Devices, Pressure Relief Devices, Pulmonary Drug Delivery Systems, Radiofrequency Ablation Devices, Remote Patient Monitoring Devices, Renal Denervation Devices, Reprocessed Medical Devices, Respiratory Devices, Respiratory Monitoring Devices, Retinal Surgery Devices, Safety Syringes, Self-Care Medical Devices, Sinus Dilation Devices, Skincare Diagnostics and Treatment Devices, Sleep Apnea Diagnostic and Therapeutic Devices, Small Animal Imaging, Small Bone and Joint Orthopedic Devices, Smart Medical Devices, Spinal Trauma Devices, Sports Medicine Devices, Tissue Sealing Agents and Hemostasis, Ultrasound Devices, Unilateral Deafness Treatment Devices, Urinary Catheters, Vitreous Tamponades, Wearable Medical Devices, Wound Closure Devices, Wound Dressing, and X-Ray Devices.The global Medical Devices market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global market research reports are divided by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global reports also provide detailed market landscape (market drivers, restraints, opportunities), market attractiveness and profitability analysis as well as profiles of major competitors in the global market which includes company overview, financial snapshot, key products, technologies and services offered, and recent developments.Browse Global Medical Devices Reports, Competitive Analytics, Growth Trends and Forecast 2017-2021 by iHealthcareAnalyst, Inc. at https://www.ihealthcareanalyst.com/ reports/medical- devices/ Table of Contents1.          Introduction2.          Executive Summary2.1.         Market Size Estimation (Revenue USD Million, 2014-2021)2.2.         Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)3.          Research Methodology4.          Market Landscape4.1.         Market Dynamics4.1.1.      Drivers4.1.2.      Barriers4.1.3.      Opportunities4.2.         Market Share Analysis4.2.1.      Companies4.2.2.      Devices4.3.         Market Trends Analysis4.3.1.      Key success factors4.3.2.      Market Growth Rate4.4.         Market Attractiveness Analysis4.5.         Market Profitability Analysis4.5.1.      Buyer power4.5.2.      Supplier power4.5.3.      Barriers to entry4.5.4.      Threat of substitute products4.5.5.      Rivalry among firms in the industry4.6.         Distribution Channels5.          Market Segmentation5.1.         Device or Brand Type5.2.         Diagnostic Test5.3.         Indication Type5.4.         Technology5.5.         Diagnostics, Therapeutic or Surgical Application5.6.         End User Groups6.          Geography (Region, Country)6.1.         North America (U.S., Canada)6.2.         Latin America (Brazil, Mexico, Rest of LA)6.3.         Europe (U.K., Germany, France, Italy, Spain, Rest of EU)6.4.         Asia Pacific (Japan, China, India, Rest of APAC)6.5.         Rest of the World7.          Regulatory Overview7.1.         Device Classification I, II, III, IV7.2.         Device (FDA, EMEA) Approvals8.          Company Profiles8.1.         Company Overview8.2.         Financial Snapshot (FY 2014-2016)8.3.         Product Portfolio8.4.         Business Strategies8.5.         Recent Developments9.          Recommendations10.          ReferencesTo request Table of Contents and Sample Pages of these reports visit:https://www.ihealthcareanalyst.com/reports/medical-devices/iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client's specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.iHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com

Loading Breast Imaging collaborators
Loading Breast Imaging collaborators